Goldwind is a wind power solution provider.
Goldwind Technology, founded in 1998, is a wind power solution provider, with three main businesses including wind turbine manufacturing, wind power services, wind farm investment and development. Founded by Xinjiang Goldwind, its employees and investors, the company went public in December 2007. Its main shareholders include Hexie Health Insurance, Xinjiang Wind Energy and Chongqing Water Conservancy. Goldwind's competitors include Vestas and Siemens.
The 2022 global cross-border e-commerce Festival kicked off ceremoniously. Chenhai group made an appearance with its brands and successfully held the brand going to sea compliance Forum
Wang Li An Fang: the annual equity distribution in 2021 is RMB 0.64 yuan, and the equity registration date is May 25
China New Energy Commercial Vehicles Market - Growth, Electrification Trend And Forecasts
As the market for new energy vehicles continues to surge in most major economies, the competition has become fierce in the field of new energy passenger cars. However,a specific type of vehicle, commercial vehicles, including buses and trucks, is still a blue ocean market, with plenty of opportunities. The commercial vehicle industry is still in its early stage in pursuing electrification, and there is a lot of room to explore different technological routes.
Mar 03, 2023 01:26 PM
Goldwind Technology: the net profit in the first quarter was 1.265 billion yuan, a year-on-year increase of 15.27%
Booking's revenue in the fourth quarter of 2021 increased by 140.79% year-on-year
ResearchReal Estate, Industrials, Financials
Tech for Global, Globalization Footprints of the Established and the New
ResearchFinancials, Automotive, Consumer Discretionary
Low-Carbon Industry Expansion - Key Studies From Chinese Companies
Yihua health: the controlling shareholder received the notice of filing a case from the CSRC
Last period: Copper inventory increased by 66213 tons this week, and aluminum inventory increased by 29888 tons
Helitai: holding Sun company listed for capital increase and share expansion to introduce investors
Yuanlong Yatu: 118925 restricted shares will be unlocked for listing and circulation
King of Acquisition, KUKA HOME's Journey to Global Expansion
At the end of 2022, the gossip of Chinese celebrity Wang Xiaofei asked his ex-wife to return his million-dollar mattress caused a buzz on social media. The netizens were again astonished by the luxurious lives of celebrities as well as informed about how lucrative the mattress business is. Today, EqualOcean will take you a glimpse of KUKA HOME(顾家家居）, a leading Chinese home furnishings brand.
Apr 25, 2023 11:30 AM
Changshan Beiming: SDIC indirectly controls 28.48% of the company's shares
Subscribe to the fruit making gift platform "fruit picking monkey" to complete the angel round financing of millions of yuan
Changjiang Securities: still optimistic about investment opportunities in wind power sector under the wave of cost reduction
Libode Completes CNY 2.578 Bn Financing to Boost Production Capacity and IPO Process
On April 12, Libode(宜宾锂宝) completed its B round of financing, with a total of CNY 2.578 billion (USD 397 million) in funding, with the goal of accelerating its IPO and completing the company's core shareholder plan.
Apr 24, 2023 11:54 AM
ESG2023 | The US Report 2023 to be Published
The EqualOcean Summit for Globalization (ESG2023) will be held in Shenzhen on June 1-2, 2023. At the ESG2023 "the US Sub-Forum", EqualOcean analysts will release the US Report 2023, which summarizes the new industry opportunities and best practices in 2023.
Apr 20, 2023 03:34 PM
Midea Group: the net profit attributable to the parent company in the third quarter was 8.446 billion yuan, a year-on-year increase of 4.40%
Laimei pharmaceutical: 99.0654 million shares held by shareholder Qiu Yu and those acting in concert will be auctioned by the judiciary
Cbcirc: deepen the reform of insurance solvency supervision and effectively prevent and resolve financial risks
Minova: rosuvastatin calcium tablets and atorvastatin calcium tablets of the joint venture have obtained the drug registration approval